^
    Apply
    Dose Finding Study of GH35 in Patients With Advanced Solid Tumors (NCT05010694)
    Phase 1
    Suzhou Genhouse Bio Co., Ltd.
    Active, not recruiting
    Last update posted :
    05/24/2024
    Initiation :
    09/27/2021
    Primary completion :
    03/22/2023
    Completion :
    12/12/2025
    KRAS
    |
    KRAS mutation
    |
    GH35